Crescent Capital BDC, Inc. (NASDAQ:CCAP)
| Market Cap | $361.09M-29.8% |
| Revenue (ttm) | $124.18M+21.0% |
| Net Income | -$156.00K-100.4% |
| EPS | -$0.01-100.8% |
| Shares Out | 36.85M |
| PE Ratio | n/a |
| Forward PE | 6.72 |
| Dividend | $1.58(16.12%) |
| Ex-Dividend Date | Dec 31, 2026 |
| Volume | 162,867 |
| Open | $9.93 |
| Previous Close | $9.97 |
| Day's Range | $9.75 - $10.05 |
| 52-Week Range | $8.39 - $15.18 |
| Beta | 0.60 |
| Analysts | Hold |
| Price Target | $10.75(+9.69%) |
| Earnings Date | Feb 24, 2027 |
About CCAP
Crescent Capital BDC, Inc. functions as a Business Development Company (BDC), managing a fund dedicated to private equity, leveraged buyouts, and providing loan capital. The firm's strategy centers on making direct investments, with a specific focus on the middle market segment. Its investment mandate is exclusively for opportunities within the United States.
Crescent Capital BDC, Inc. Stock Analysis — InsiderScore
Crescent Capital BDC, Inc. scored higher than 80% of companies evaluated by InsiderBuying, and ranked 32nd out of 253 stocks in the financials sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Crescent Capital BDC, Inc. bought $70.1K of stock across 2 purchases in the last 90 days, the largest of them $49.9K.
The average purchase added about 7% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
3 firms rating CCAP in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 31, 2026Ex-dividend date
- Feb 24, 2027Earnings report
$CCAP stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CCAP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CCAP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CCAP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CCAP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CCAP from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CCAP
| KBWDInvesco KBW High Dividend Yield Financial ETF | $8.83M |
| VPCVirtus Private Credit Strategy ETF | $551.70K |
| CEFZRiverNorth Active Income ETF | $190.15K |
| MSSMMorgan Stanley Pathway Funds - Small-Mid Cap Equity ETF | $31.82K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from CCAP’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat estimates, NII topped dividend forecasts, new JV announced, 34% analyst upside identified, and $50M buyback initiated.
Recent Insider Activity
Insider Score Trend Over Time
+23.1 since Sep 22Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
